Literature DB >> 6539167

Involvement of plasminogen activator production with tumor metastasis in a rat model.

S A Carlsen, I A Ramshaw, R C Warrington.   

Abstract

The process of metastasis involves numerous steps, many of which are thought to require the action of hydrolases, such as collagenase and other proteases. In this study, we investigate the role of the protease plasminogen activator in the metastasis of the rat mammary adenocarcinoma 13762. We observed that this tumor cell line is heterogeneous with respect to plasminogen activator (PAA) production. Clonal tumor cell populations were isolated which produced various levels of PAA. This phenotypic property of these clones remained stable for long periods of in vitro culture and did not affect their tumorigenicity. When the metastatic potential of these clones was determined using the lung colony assay, a strong correlation between PAA and metastatic potential was found. Furthermore, a threshold level of PAA production was observed, above which the lung colony-forming ability of the cells increased dramatically. These studies suggest that PAA production may play an important role in tumor metastasis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6539167

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

Review 1.  A systems approach to cancer therapy. (Antioncogenics + standard cytotoxics-->mechanism(s) of interaction).

Authors:  B A Teicher
Journal:  Cancer Metastasis Rev       Date:  1996-06       Impact factor: 9.264

2.  The identification of a neutral glycosphingolipid antigenic marker for metastatic cells in the R3230AC rat mammary adenocarcinoma.

Authors:  S A Carlsen; M Barry; K Newton
Journal:  Clin Exp Metastasis       Date:  1990 Mar-Apr       Impact factor: 5.150

Review 3.  The role of proteolytic enzymes in cancer invasion and metastasis.

Authors:  M J Duffy
Journal:  Clin Exp Metastasis       Date:  1992-05       Impact factor: 5.150

4.  Expression of human recombinant plasminogen activators enhances invasion and experimental metastasis of H-ras-transformed NIH 3T3 cells.

Authors:  J H Axelrod; R Reich; R Miskin
Journal:  Mol Cell Biol       Date:  1989-05       Impact factor: 4.272

Review 5.  Studies on rat mammary adenocarcinomas: a model for metastasis.

Authors:  I A Ramshaw; P Badenoch-Jones
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

6.  Clonal heterogeneity in plasminogen activator activity produced by two murine tumor cell lines.

Authors:  L H Brail; R P Hill
Journal:  Clin Exp Metastasis       Date:  1995-11       Impact factor: 5.150

7.  Heterogeneities of attachment, chemotaxis, and protease production among clones with different metastatic potentials from a human pancreatic cancer cell line.

Authors:  S Taniguchi; T Iwamura; N Kitamura; H Yamanari; T Setoguchi
Journal:  Clin Exp Metastasis       Date:  1994-05       Impact factor: 5.150

Review 8.  Metastasis suppressor genes at the interface between the environment and tumor cell growth.

Authors:  Douglas R Hurst; Danny R Welch
Journal:  Int Rev Cell Mol Biol       Date:  2011       Impact factor: 6.813

9.  In vitro inhibition of human sarcoma cells' invasive ability by bis(5-amidino-2-benzimidazolyl)methane--a novel esteroprotease inhibitor.

Authors:  D H Cresson; W C Beckman; R R Tidwell; J D Geratz; G P Siegal
Journal:  Am J Pathol       Date:  1986-04       Impact factor: 4.307

10.  Urokinase-type plasminogen activator activity increases during the growth of two murine mammary adenocarcinomas with different metastasizing abilities.

Authors:  S Pereyra-Alfonso; G R Solarz; E Bal de Kier Joffé
Journal:  Clin Exp Metastasis       Date:  1992-11       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.